Costs of treating serious adverse effects of drugs used for treatment of obesity: comparison of selected European countries
Drugs for the treatment of obesity show significant effectiveness, but the adverse effects (ADRs) of these drugs are numerous and varied, and some of them are highly cost-generating. Our research aimed to define the health care utilization pattern in treating ADRs of antiobesity therapy, to compare...
Saved in:
| Main Authors: | Branislava Raičević, Ivana Stević, Dragana Lakić, Agnes Männik, Kalina Gjorgjievska, Bojan Labachevski, Kristina Pavlovska, Miodrag Žunić, Petya Milushewa, Guenka Petrova, Dominik Grega, Przemysław Holko, Slobodan M. Janković |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Biotechnology & Biotechnological Equipment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2024.2422546 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis
by: Ana Antanasković, et al.
Published: (2023-03-01) -
Costs of treating type 2 diabetes mellitus and its complications
by: Nemanja Petrović, et al.
Published: (2024-12-01) -
Response to the Letter to the Editor concerning ‘Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’
by: Ivana Stević, et al.
Published: (2024-12-01) -
Cost-effectiveness of therapeutic drug monitoring (TDM) of biologic treatment in rheumatic diseases: a narrative review
by: Konstantin Tachkov, et al.
Published: (2023-03-01) -
VECTORS OF TURKISH FOREIGN POLICY: WHAT REMAINS OF THE STRATEGY FOR 2023?
by: Slobodan Janković
Published: (2016-03-01)